invasive fungal infection Clinical Trials

10 recruitingLast updated: May 11, 2026

There are 10 actively recruiting invasive fungal infection clinical trials across 18 countries. Studies span Phase 2, Phase 1. Top locations include Durham, North Carolina, United States, Chicago, Illinois, United States, Austin, Texas, United States. Updated daily from ClinicalTrials.gov.


invasive fungal infection Trials at a Glance

10 actively recruiting trials for invasive fungal infection are listed on ClinicalTrialsFinder across 6 cities in 18 countries. The largest study group is Phase 2 with 2 trials, with the heaviest enrollment activity in Durham, Chicago, and Austin. Lead sponsors running invasive fungal infection studies include Assistance Publique - Hôpitaux de Paris, Biosergen AS, and Arkansas Children's Hospital Research Institute.

Browse invasive fungal infection trials by phase

About invasive fungal infection Clinical Trials

Looking for clinical trials for invasive fungal infection? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new invasive fungal infection trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about invasive fungal infection clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting

Immunomonitoring of Mold Invasive Infections

Invasive Fungal DiseaseMold Invasive Fungal Infection: Aspergillus, Mucorales, Fusarium, Scedosporium
Assistance Publique - Hôpitaux de Paris20 enrolled1 locationNCT06285188
Recruiting
Phase 2

Posaconazole (MK-5592) Intravenous and Oral in Children (<2 Years) With Invasive Fungal Infection (MK-5592-127)

invasive fungal infection
Merck Sharp & Dohme LLC40 enrolled26 locationsNCT04665037
Recruiting

Siderophore-labelled Positron Emission Tomography for Correlating Invasive Fungal InfeCtions

Invasive Fungal Infections
Peter MacCallum Cancer Centre, Australia10 enrolled1 locationNCT06105411
Recruiting

Incidence of Invasive Fungal Infections Among Patients With Acute Lymphoblastic Leukemia Ph-negative

Invasive Fungal InfectionsAcute Lymphoblastic Leukemia, Adult
Fondazione Policlinico Universitario Agostino Gemelli IRCCS150 enrolled1 locationNCT05750706
Recruiting

Breath Analysis for the Detection of Invasive Fungal Infections

LeukemiaLeukemia, MyeloidLeukemia, Lymphoblastic+4 more
University of Zurich130 enrolled1 locationNCT06537726
Recruiting
Phase 1Phase 2

Study to Assess the Safety and Efficacy of Intravenous BSG005 in Patients With Invasive Fungal Infection

invasive fungal infection
Biosergen AS15 enrolled1 locationNCT06678113
Recruiting

Usefulness of PET-CT for Invasive Fungal Infection

Invasive Fungal Infections
Puerta de Hierro University Hospital224 enrolled14 locationsNCT05688592
Recruiting

Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections

Pulmonary Invasive Fungal InfectionsPulmonary Invasive Aspergillosis
Arkansas Children's Hospital Research Institute400 enrolled33 locationsNCT03827694
Recruiting

Retrospective Study of Invasive Fungal Infections With Filamentous Fungi in Heart Transplant Patients

Invasive Fungal Infections
University Hospital, Strasbourg, France100 enrolled1 locationNCT06498310
Recruiting

Fungal Surveillance in Bangladesh

Invasive Fungal Infections
International Centre for Diarrhoeal Disease Research, Bangladesh800 enrolled1 locationNCT06103331